MAP2K3 and cancer: As MKK3 plays a role in pain signaling, inflammation and cancer [29, 30], we hypothesized that reciprocal methylation of DMR1 and DMR2 would instruct differential MKK3 protein expression leading to altered RAS signaling fates.